Bellicum Pharmaceuticals, Inc.

[NASDAQ: BLCM]; based in Houston, Texas; incorporated in Delaware

Lead Plaintiff Deadline: 04/09/2018

Case #: 18-cv-338

Court: USDC, Southern District of Texas

Notes: Lead or Derivative Plaintiffs; Class Period is 5/8/2017 to 1/40/2018